The full text of this article hosted at iucr.org is unavailable due to technical difficulties.

Arthritis and cannabinoids: HU‐210 and Win‐55,212–2 prevent IL‐1 α‐induced matrix degradation in bovine articular chondrocytes in‐vitro

Estery C. Mbvundula

Biomedical Research Centre, Sheffield Hallam University, Sheffield, S1 1WB, UK

Search for more papers by this author
Rowena A. D. Bunning

Biomedical Research Centre, Sheffield Hallam University, Sheffield, S1 1WB, UK

Search for more papers by this author
K. D. Rainsford

Corresponding Author

Biomedical Research Centre, Sheffield Hallam University, Sheffield, S1 1WB, UK

Biomedical Research Centre, Faculty of Health and Wellbeing, Sheffield Hallam University, Howard Street, Sheffield, S1 1WB, UK. E‐mail:

Search for more papers by this author
First published: 18 February 2010
Cited by: 22

Abstract

Cannabinoids have analgesic, immunomodulatory and anti‐inflammatory properties and attenuate joint damage in animal models of arthritis. In this study the mechanisms of action of the synthetic cannabinoid agonists, HU‐210 and Win‐55,212–2, were studied to determine if they affected interleukin‐1 alpha (IL‐1α)‐induced proteoglycan and collagen degradation in bovine nasal cartilage explant cultures and prostaglandin E2 (PGE2) production in primary cultures of bovine articular chondrocytes. The effects of the inactive enantiomer, Win‐55,212–3, were compared with those of the active enantiomer, Win‐55,212–2, to determine if the effects were cannabinoid (CB)‐receptor mediated. The chondrocytes and explants were stimulated by IL‐1α (100 U mL−1 ≡ 0.06 nm and 500 U mL−1 ≡ 0.3 nm, respectively). Proteoglycan breakdown was determined as sulfated glycosaminoglycan (sGAG) release using the dimethylmethylene blue assay. Collagen degradation was determined as hydroxyproline in the conditioned culture media and cartilage digests. PGE2 was determined by ELISA. Expression of cannabinoid receptors, CB1 and CB2; cyclooxygenase‐1 and −2 (COX‐1 and COX‐2); inducible nitric oxide synthase (iNOS); as well as activation of nuclear factor‐kappa B (NF‐κB) in chondrocytes were studied using immunoblotting techniques and immunofluorescence. The results showed that HU‐210 and Win‐55,212–2 (5–15 μm) significantly inhibited IL‐1α‐stimulated proteoglycan (P < 0.001) and collagen degradation (P < 0.001). Win‐55,212–2 (5–10 μm) also significantly inhibited PGE2 production (P < 0.01). At 5 μm, Win‐55,212–2 inhibited the expression of iNOS and COX‐2 and activation of NF‐κB. Chondrocytes appeared to constitutively express cannabinoid receptors CB1 and CB2. It is concluded that biologically stable synthetic cannabinoids protect cartilage matrix from degradation induced by cytokines and this effect is possibly CB‐receptor mediated and involves effects on prostaglandin and nitric oxide metabolism. Cannabinoids could also be producing these effects via inhibition of NF‐κB activation.

Number of times cited according to CrossRef: 22

  • , The Endogenous Cannabinoid System: A Budding Source of Targets for Treating Inflammatory and Neuropathic Pain, Neuropsychopharmacology, 10.1038/npp.2017.204, 43, 1, (52-79), (2017)., (2017).
  • , Activation of the cannabinoid receptor 1 by ACEA suppresses senescence in human primary chondrocytes through sirt1 activation, Experimental Biology and Medicine, 10.1177/1535370218757950, 243, 5, (437-443), (2018).
  • , Characterization of endocannabinoids and related acylethanolamides in the synovial fluid of dogs with osteoarthritis: a pilot study, BMC Veterinary Research, 13, 1, (2017).
  • , Cannabinoids and autoimmune diseases: A systematic review, Autoimmunity Reviews, 10.1016/j.autrev.2016.02.008, 15, 6, (513-528), (2016).
  • , Cannabinoid WIN-55,212-2 mesylate inhibits ADAMTS-4 activity in human osteoarthritic articular chondrocytes by inhibiting expression of syndecan-1, Molecular Medicine Reports, 10.3892/mmr.2016.5137, 13, 6, (4569-4576), (2016).
  • , Expression of Cannabinoid Receptors in Human Osteoarthritic Cartilage: Implications for Future Therapies, Cannabis and Cannabinoid Research, 10.1089/can.2015.0001, 1, 1, (3-15), (2016).
  • , Activation of cannabinoid receptor 2 attenuates synovitis and joint distruction in collagen-induced arthritis, Immunobiology, 220, 6, (817), (2015).
  • , The type 2 cannabinoid receptor regulates susceptibility to osteoarthritis in mice, Osteoarthritis and Cartilage, 23, 9, (1586), (2015).
  • , The endocannabinoid system and its therapeutic implications in rheumatoid arthritis, International Immunopharmacology, 10.1016/j.intimp.2015.03.006, 26, 1, (86-91), (2015).
  • , Involvement of the endocannabinoid system in osteoarthritis pain, European Journal of Neuroscience, 39, 3, (485-500), (2014).
  • , Cannabinoid WIN-55,212-2 mesylate inhibits interleukin-1β induced matrix metalloproteinase and tissue inhibitor of matrix metalloproteinase expression in human chondrocytes, Osteoarthritis and Cartilage, 10.1016/j.joca.2013.10.016, 22, 1, (133-144), (2014).
  • , Trans-caryophyllene suppresses tumor necrosis factor (TNFα)-induced inflammation in human chondrocytes, European Food Research and Technology, 239, 6, (1061), (2014).
  • , Expression of cannabinoid receptor 2 and its inhibitory effects on synovial fibroblasts in rheumatoid arthritis, Rheumatology, 53, 5, (802), (2014).
  • , Cannabinoid Receptor 2 Activation, The American Journal of Pathology, 183, 5, (1375), (2013).
  • , Role of CB1 and CB2 cannabinoid receptors in the development of joint pain induced by monosodium iodoacetate, Pain, 10.1016/j.pain.2012.10.009, 154, 1, (160-174), (2013).
  • , Cannabinoids: novel therapies for arthritis?, Future Medicinal Chemistry, 10.4155/fmc.12.20, 4, 6, (713-725), (2012).
  • , Inhibition of acid-sensing ion channels in articular chondrocytes by amiloride attenuates articular cartilage destruction in rats with adjuvant arthritis, Inflammation Research, 10.1007/s00011-010-0206-4, 59, 11, (939-947), (2010).
  • , Inhibition of cyclooxygenase 2 expression by diallyl sulfide on joint inflammation induced by urate crystal and IL-1β, Osteoarthritis and Cartilage, 10.1016/j.joca.2008.05.010, 17, 1, (91-99), (2009).
  • , Osteoarthritic pain: a review of current, theoretical and emerging therapeutics, Expert Opinion on Investigational Drugs, 10.1517/13543784.17.5.619, 17, 5, (619-640), (2008).
  • , Local administration of WIN 55,212-2 reduces chronic granuloma-associated angiogenesis in rat by inhibiting NF-κB activation, Journal of Molecular Medicine, 10.1007/s00109-007-0188-z, 85, 6, (635-645), (2007).
  • , Tissue Engineering of Cartilage; Can Cannabinoids Help?, Pharmaceuticals, 10.3390/ph3092970, 3, 9, (2970-2985), (2010).
  • , Joint problems arising from lack of repair mechanisms: can cannabinoids help?, British Journal of Pharmacology, , (2018).